The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Parsabiv is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on haemodialysis therapy.